annual book value:
$185.44M-$85.90M(-31.66%)Summary
- As of today (September 10, 2025), ARWR annual book value is $185.44 million, with the most recent change of -$85.90 million (-31.66%) on September 30, 2024.
- During the last 3 years, ARWR annual book value has fallen by -$223.38 million (-54.64%).
- ARWR annual book value is now -59.84% below its all-time high of $461.78 million, reached on September 30, 2020.
Performance
ARWR Book value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly book value:
$522.31M-$161.01M(-23.56%)Summary
- As of today (September 10, 2025), ARWR quarterly book value is $522.31 million, with the most recent change of -$161.01 million (-23.56%) on June 30, 2025.
- Over the past year, ARWR quarterly book value has increased by +$191.77 million (+58.01%).
- ARWR quarterly book value is now -23.56% below its all-time high of $683.32 million, reached on March 31, 2025.
Performance
ARWR quarterly book value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Book value Formula
Book Value = Total Assets − Total Liabilities
ARWR Book value Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.7% | +58.0% |
| 3 y3 years | -54.6% | +15.1% |
| 5 y5 years | -24.2% | +5.9% |
ARWR Book value Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -54.6% | at low | -23.6% | +893.2% |
| 5 y | 5-year | -59.8% | at low | -23.6% | +893.2% |
| alltime | all time | -59.8% | +6728.2% | -23.6% | >+9999.0% |
ARWR Book value History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $522.31M(-23.6%) |
| Mar 2025 | - | $683.32M(+1199.3%) |
| Dec 2024 | - | $52.59M(-71.6%) |
| Sep 2024 | $185.44M(-31.7%) | $185.44M(-43.9%) |
| Jun 2024 | - | $330.55M(-31.7%) |
| Mar 2024 | - | $483.79M(+201.6%) |
| Dec 2023 | - | $160.41M(-40.9%) |
| Sep 2023 | $271.34M(-31.9%) | $271.34M(-25.6%) |
| Jun 2023 | - | $364.83M(-18.3%) |
| Mar 2023 | - | $446.77M(+18.5%) |
| Dec 2022 | - | $377.04M(-5.4%) |
| Sep 2022 | $398.52M(-2.5%) | $398.52M(-12.2%) |
| Jun 2022 | - | $453.93M(+0.4%) |
| Mar 2022 | - | $452.27M(+21.4%) |
| Dec 2021 | - | $372.56M(-8.9%) |
| Sep 2021 | $408.82M(-11.5%) | $408.82M(-6.4%) |
| Jun 2021 | - | $436.89M(-1.9%) |
| Mar 2021 | - | $445.55M(-2.0%) |
| Dec 2020 | - | $454.47M(-1.6%) |
| Sep 2020 | $461.78M(+88.8%) | $461.78M(-6.4%) |
| Jun 2020 | - | $493.14M(-0.2%) |
| Mar 2020 | - | $494.12M(-1.2%) |
| Dec 2019 | - | $500.08M(+104.5%) |
| Sep 2019 | $244.59M(+155.3%) | $244.59M(+8.1%) |
| Jun 2019 | - | $226.22M(+12.4%) |
| Mar 2019 | - | $201.20M(+16.9%) |
| Dec 2018 | - | $172.06M(+79.6%) |
| Sep 2018 | $95.80M(+17.7%) | $95.80M(-6.4%) |
| Jun 2018 | - | $102.31M(-10.5%) |
| Mar 2018 | - | $114.27M(+61.5%) |
| Dec 2017 | - | $70.75M(-13.1%) |
| Sep 2017 | $81.42M(-14.8%) | $81.42M(-9.6%) |
| Jun 2017 | - | $90.10M(-4.0%) |
| Mar 2017 | - | $93.89M(-4.0%) |
| Dec 2016 | - | $97.76M(+2.3%) |
| Sep 2016 | $95.58M(-13.2%) | $95.58M(+59.4%) |
| Jun 2016 | - | $59.98M(-19.5%) |
| Mar 2016 | - | $74.48M(-19.8%) |
| Dec 2015 | - | $92.92M(-15.7%) |
| Sep 2015 | $110.18M(-33.8%) | $110.18M(-16.1%) |
| Jun 2015 | - | $131.30M(-9.3%) |
| Mar 2015 | - | $144.75M(-1.0%) |
| Dec 2014 | - | $146.26M(-12.2%) |
| Sep 2014 | $166.54M(+505.6%) | $166.54M(-10.6%) |
| Jun 2014 | - | $186.36M(-2.6%) |
| Mar 2014 | - | $191.40M(+131.3%) |
| Dec 2013 | - | $82.73M(+200.9%) |
| Sep 2013 | $27.50M(+174.6%) | $27.50M(-21.3%) |
| Jun 2013 | - | $34.96M(+558.0%) |
| Mar 2013 | - | $5.31M(-49.3%) |
| Dec 2012 | - | $10.47M(-5.0%) |
| Sep 2012 | $10.01M | $11.03M(+6.4%) |
| Jun 2012 | - | $10.37M(-30.4%) |
| Mar 2012 | - | $14.90M(-25.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | - | $20.07M(+46.6%) |
| Sep 2011 | $12.79M(+41.4%) | $13.69M(+28.8%) |
| Jun 2011 | - | $10.63M(-12.1%) |
| Mar 2011 | - | $12.09M(+50.1%) |
| Dec 2010 | - | $8.05M(-11.0%) |
| Sep 2010 | $9.05M(+86.2%) | $9.05M(-10.6%) |
| Jun 2010 | - | $10.11M(+72.1%) |
| Mar 2010 | - | $5.88M(-8.6%) |
| Dec 2009 | - | $6.43M(+32.3%) |
| Sep 2009 | $4.86M(-60.5%) | $4.86M(+30.8%) |
| Jun 2009 | - | $3.71M(+814.6%) |
| Mar 2009 | - | $406.10K(-91.9%) |
| Dec 2008 | - | $5.00M(-59.4%) |
| Sep 2008 | $12.30M(-53.2%) | $12.30M(-6.1%) |
| Jun 2008 | - | $13.10M(-31.3%) |
| Mar 2008 | - | $19.06M(-19.8%) |
| Dec 2007 | - | $23.77M(-9.6%) |
| Sep 2007 | $26.30M(-14.2%) | $26.30M(-20.7%) |
| Jun 2007 | - | $33.18M(+35.5%) |
| Mar 2007 | - | $24.48M(-18.8%) |
| Dec 2006 | - | $30.16M(-1.7%) |
| Sep 2006 | $30.67M(+17.4%) | $30.67M(-18.5%) |
| Jun 2006 | - | $37.62M(-8.7%) |
| Mar 2006 | - | $41.20M(+76.6%) |
| Dec 2005 | - | $23.33M(-10.7%) |
| Sep 2005 | $26.13M(+176.5%) | $26.13M(-8.2%) |
| Jun 2005 | - | $28.46M(+128.7%) |
| Mar 2005 | - | $12.44M(+51.3%) |
| Dec 2004 | - | $8.22M(-13.0%) |
| Sep 2004 | $9.45M(+565.5%) | $9.45M(-12.9%) |
| Jun 2004 | - | $10.85M(-5.4%) |
| Mar 2004 | - | $11.47M(+444.3%) |
| Dec 2003 | - | $2.11M(+48.4%) |
| Sep 2003 | $1.42M(-191.4%) | $1.42M(-169.1%) |
| Jun 2003 | - | -$2.05M(+2.7%) |
| Mar 2003 | - | -$2.00M(+5.5%) |
| Dec 2002 | - | -$1.90M(+2.4%) |
| Sep 2002 | -$1.55M(+18.8%) | -$1.85M(+4.8%) |
| Jun 2002 | - | -$1.77M(+5.3%) |
| Mar 2002 | - | -$1.68M(+0.6%) |
| Dec 2001 | - | -$1.67M(+3.9%) |
| Sep 2001 | -$1.31M(+15.5%) | -$1.60M(+4.0%) |
| Jun 2001 | - | -$1.54M(+2.2%) |
| Mar 2001 | - | -$1.51M(-7.4%) |
| Dec 2000 | - | -$1.63M(+1.9%) |
| Sep 2000 | -$1.13M(+13.3%) | -$1.60M(-2.1%) |
| Jun 2000 | - | -$1.64M(+3.6%) |
| Mar 2000 | - | -$1.58M(+3.4%) |
| Dec 1999 | - | -$1.53M(+3.9%) |
| Sep 1999 | -$998.20K(-64.3%) | -$1.47M(+55.4%) |
| Jun 1999 | - | -$944.70K(-63.3%) |
| Mar 1999 | - | -$2.57M |
| Sep 1998 | -$2.80M(+8.6%) | - |
| Sep 1997 | -$2.58M | - |
FAQ
- What is Arrowhead Pharmaceuticals, Inc. annual book value?
- What is the all time high annual book value for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. annual book value year-on-year change?
- What is Arrowhead Pharmaceuticals, Inc. quarterly book value?
- What is the all time high quarterly book value for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. quarterly book value year-on-year change?
What is Arrowhead Pharmaceuticals, Inc. annual book value?
The current annual book value of ARWR is $185.44M
What is the all time high annual book value for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high annual book value is $461.78M
What is Arrowhead Pharmaceuticals, Inc. annual book value year-on-year change?
Over the past year, ARWR annual book value has changed by -$85.90M (-31.66%)
What is Arrowhead Pharmaceuticals, Inc. quarterly book value?
The current quarterly book value of ARWR is $522.31M
What is the all time high quarterly book value for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high quarterly book value is $683.32M
What is Arrowhead Pharmaceuticals, Inc. quarterly book value year-on-year change?
Over the past year, ARWR quarterly book value has changed by +$191.77M (+58.01%)